CLINICAL_TRIALS
trial_result
· 2017-01-18
Clinical Trial Update: BIIB023 Long-Term Extension Study in Subjects With Lupus Nephritis [Phase 2]
Summary
A Phase 2 long-term extension study of BIIB023 in lupus nephritis was terminated, with results posted in January 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Biogen | Conditions: Lupus Nephritis | Phase 2 | Status: TERMINATED | Results posted: 2017-01-18